193 related articles for article (PubMed ID: 25403448)
21. Inherent Tumor Characteristics That Limit Effective and Safe Resection of Giant Nonfunctioning Pituitary Adenomas.
Nishioka H; Hara T; Nagata Y; Fukuhara N; Yamaguchi-Okada M; Yamada S
World Neurosurg; 2017 Oct; 106():645-652. PubMed ID: 28735124
[TBL] [Abstract][Full Text] [Related]
22. Patterns of extrasellar extension in growth hormone-secreting and nonfunctional pituitary macroadenomas.
Zada G; Lin N; Laws ER
Neurosurg Focus; 2010 Oct; 29(4):E4. PubMed ID: 20887129
[TBL] [Abstract][Full Text] [Related]
23. MR imaging of cavernous sinus involvement by pituitary adenomas.
Scotti G; Yu CY; Dillon WP; Norman D; Colombo N; Newton TH; De Groot J; Wilson CB
AJR Am J Roentgenol; 1988 Oct; 151(4):799-806. PubMed ID: 3262283
[TBL] [Abstract][Full Text] [Related]
24. MR imaging features of thyrotropin-secreting pituitary adenomas at initial presentation.
Sarlis NJ; Gourgiotis L; Koch CA; Skarulis MC; Brucker-Davis F; Doppman JL; Oldfield EH; Patronas NJ
AJR Am J Roentgenol; 2003 Aug; 181(2):577-82. PubMed ID: 12876051
[TBL] [Abstract][Full Text] [Related]
25. Are nonfunctioning pituitary adenomas extending into the cavernous sinus aggressive and/or invasive?
Yokoyama S; Hirano H; Moroki K; Goto M; Imamura S; Kuratsu JI
Neurosurgery; 2001 Oct; 49(4):857-62; discussion 862-3. PubMed ID: 11564246
[TBL] [Abstract][Full Text] [Related]
26. Endothelial cell-specific molecule-1 as an invasiveness marker for pituitary null cell adenoma.
Wang S; Wu Z; Wei L; Zhang J
BMC Endocr Disord; 2019 Aug; 19(1):90. PubMed ID: 31455321
[TBL] [Abstract][Full Text] [Related]
27. Invasion of the cavernous sinus space in pituitary adenomas: endoscopic verification and its correlation with an MRI-based classification.
Micko AS; Wöhrer A; Wolfsberger S; Knosp E
J Neurosurg; 2015 Apr; 122(4):803-11. PubMed ID: 25658782
[TBL] [Abstract][Full Text] [Related]
28. Pituitary magnetic resonance imaging findings do not influence surgical outcome in adrenocorticotropin-secreting microadenomas.
Salenave S; Gatta B; Pecheur S; San-Galli F; Visot A; Lasjaunias P; Roger P; Berge J; Young J; Tabarin A; Chanson P
J Clin Endocrinol Metab; 2004 Jul; 89(7):3371-6. PubMed ID: 15240617
[TBL] [Abstract][Full Text] [Related]
29. A study of the correlation between morphological findings and biological activities in clinically nonfunctioning pituitary adenomas.
Yamada S; Ohyama K; Taguchi M; Takeshita A; Morita K; Takano K; Sano T
Neurosurgery; 2007 Sep; 61(3):580-4; discussion 584-5. PubMed ID: 17881972
[TBL] [Abstract][Full Text] [Related]
30. Thyroid-stimulating hormone pituitary adenomas.
Clarke MJ; Erickson D; Castro MR; Atkinson JL
J Neurosurg; 2008 Jul; 109(1):17-22. PubMed ID: 18590428
[TBL] [Abstract][Full Text] [Related]
31. Clinical importance of the basal cavernous sinuses and cavernous carotid arteries relative to the pituitary gland and macroadenomas: quantitative analysis of the complete anatomy.
Yilmazlar S; Kocaeli H; Eyigor O; Hakyemez B; Korfali E
Surg Neurol; 2008 Aug; 70(2):165-74; discussion 174-5. PubMed ID: 18262607
[TBL] [Abstract][Full Text] [Related]
32. Significant improvement of intractable headache after transsphenoidal surgery in patients with pituitary adenomas; preoperative neuroradiological evaluation and intraoperative intrasellar pressure measurement.
Hayashi Y; Kita D; Iwato M; Fukui I; Oishi M; Tsutsui T; Tachibana O; Nakada M
Pituitary; 2016 Apr; 19(2):175-82. PubMed ID: 26659379
[TBL] [Abstract][Full Text] [Related]
33. Endoscopic endonasal transsphenoidal surgery for functional pituitary adenomas.
Hofstetter CP; Shin BJ; Mubita L; Huang C; Anand VK; Boockvar JA; Schwartz TH
Neurosurg Focus; 2011 Apr; 30(4):E10. PubMed ID: 21456921
[TBL] [Abstract][Full Text] [Related]
34. Radiosurgery for residual or recurrent nonfunctioning pituitary adenoma.
Sheehan JP; Kondziolka D; Flickinger J; Lunsford LD
J Neurosurg; 2002 Dec; 97(5 Suppl):408-14. PubMed ID: 12507066
[TBL] [Abstract][Full Text] [Related]
35. Basis of persistent and recurrent Cushing disease: an analysis of findings at repeated pituitary surgery.
Dickerman RD; Oldfield EH
J Neurosurg; 2002 Dec; 97(6):1343-9. PubMed ID: 12507132
[TBL] [Abstract][Full Text] [Related]
36. The Complementary Role of Transcription Factors in the Accurate Diagnosis of Clinically Nonfunctioning Pituitary Adenomas.
Nishioka H; Inoshita N; Mete O; Asa SL; Hayashi K; Takeshita A; Fukuhara N; Yamaguchi-Okada M; Takeuchi Y; Yamada S
Endocr Pathol; 2015 Dec; 26(4):349-55. PubMed ID: 26481628
[TBL] [Abstract][Full Text] [Related]
37. Impact of ultra-low-field intraoperative magnetic resonance imaging on extent of resection and frequency of tumor recurrence in 104 surgically treated nonfunctioning pituitary adenomas.
Hlavica M; Bellut D; Lemm D; Schmid C; Bernays RL
World Neurosurg; 2013 Jan; 79(1):99-109. PubMed ID: 23043996
[TBL] [Abstract][Full Text] [Related]
38. Aggressive transsphenoidal resection of tumors invading the cavernous sinus in patients with acromegaly: predictive factors, strategies, and outcomes.
Nishioka H; Fukuhara N; Horiguchi K; Yamada S
J Neurosurg; 2014 Sep; 121(3):505-10. PubMed ID: 25014437
[TBL] [Abstract][Full Text] [Related]
39. Comparison of outcomes between a less experienced surgeon using a fully endoscopic technique and a very experienced surgeon using a microscopic transsphenoidal technique for pituitary adenoma.
Zaidi HA; Awad AW; Bohl MA; Chapple K; Knecht L; Jahnke H; White WL; Little AS
J Neurosurg; 2016 Mar; 124(3):596-604. PubMed ID: 26473774
[TBL] [Abstract][Full Text] [Related]
40. [Pituitary adenomas: neurosurgical treatment].
Wolfsberger S; Czech T; Knosp E
Wien Klin Wochenschr; 2003; 115 Suppl 2():28-32. PubMed ID: 15518143
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
